Cost-Effectiveness Analysis of a Virtual Reality-Assisted Hypnotherapy Program on Quality of Life in Patients with Chronic Neck Pain: a Multicenter, Randomized, Prospective, Comparative, Open-Label, Parallel-Group Study
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized, prospective study aims to evaluate the effectiveness and cost-efficiency of a Virtual Reality (VR)-assisted hypnotherapy program on quality of life in patients with chronic neck pain. The study compares a VR-assisted hypnotherapy group to a standard treatment group. Both groups will undergo a conventional physical therapy program supervised by physiotherapists for 3 weeks (15 sessions). The VR-assisted hypnotherapy group will receive additional sessions utilizing the HypnoVR software, which delivers relaxing virtual environments. Outcomes will be assessed immediately after treatment, at 1 month, and at 3 months post-treatment. Primary endpoints include pain reduction measured by the Visual Analog Scale (VAS). Secondary endpoints include functionality, quality of life, anxiety, depression, sleep quality, healthcare costs, and treatment adherence. Statistical analyses will determine the efficacy and economic impact of this innovative therapy for chronic neck pain management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
November 20, 2024
CompletedStudy Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedNovember 20, 2024
November 1, 2024
4 months
November 18, 2024
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity
The primary outcome is the percentage change in pain intensity, measured using the Visual Analog Scale (VAS). A reduction of ≥30% in the VAS score from baseline is considered clinically significant.
Assessed at baseline, immediately after treatment (3 weeks), and at 1- and 3-month follow-ups.
Secondary Outcomes (5)
Change in Functional Status
Baseline, post-treatment (3 weeks), and at 1- and 3-month follow-ups.
Change in Quality of Life
Baseline, post-treatment (3 weeks), and at 1- and 3-month follow-ups.
Reduction in Analgesic Use
Baseline and weekly throughout the 3-month follow-up period.
Change in Anxiety and Depression Levels
Baseline, post-treatment (3 weeks), and at 1- and 3-month follow-ups.
Reduction in Healthcare Utilization
Assessed retrospectively at baseline and at the 3-month follow-up.
Study Arms (2)
Virtual Reality-Assisted Hypnotherapy+Physiotherapy Group
EXPERIMENTALParticipants in this arm will undergo a conventional physical therapy program for 3 weeks (15 sessions) supervised by physiotherapists. Additionally, during each physical therapy session, participants will receive a 20-minute Virtual Reality (VR)-assisted hypnotherapy session using the HypnoVR software.
Standard Treatment Group
ACTIVE COMPARATORParticipants in this arm will undergo a conventional physical therapy program for 3 weeks (15 sessions) supervised by physiotherapists.
Interventions
Virtual Reality-Assisted Hypnotherapy utilizes HypnoVR software delivered through VR glasses to provide a relaxing virtual environment. The intervention is integrated into a standard physical therapy program, with participants receiving 20-minute VR-assisted hypnotherapy sessions during each of the 15 supervised physical therapy sessions over a 3-week period. This approach aims to improve pain management, quality of life, and adherence to treatment in patients with chronic neck pain.
Participants in the control group will undergo a standard physical therapy program focused on the cervical region, consisting of 15 sessions over 3 weeks. Each session will be supervised by physiotherapists in a clinical setting and will include traditional physical therapy techniques such as therapeutic exercises
Eligibility Criteria
You may qualify if:
- Age between 50 and 80 years.
- Chronic neck pain lasting for more than 3 months.
You may not qualify if:
- History of spinal surgery.
- Beck Depression Inventory (BDI) score \>16.
- Presence of neurological deficits or concurrent neurological diseases.
- Medical conditions incompatible with the use of VR headsets (e.g., vision problems, epilepsy).
- Pregnancy.
- Recent changes in medication for chronic pain within the past 3 months (e.g.,- Pregabalin, Gabapentin, Duloxetine).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beykent University Faculty of Medicine, Physical Therapy Unit
Istanbul, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 18, 2024
First Posted
November 20, 2024
Study Start
December 2, 2024
Primary Completion
April 1, 2025
Study Completion
July 1, 2025
Last Updated
November 20, 2024
Record last verified: 2024-11